A controlled trial of nystatin for the candidiasis hypersensitivity syndrome

William G. Crook, C. Orian Truss, Carroll V. Truss, Maria M. Llabre, Robert Brian Cutler, William J. Ledger, Steven S. Witkin, Marjorie Crandall, William E. Dismukes, Jeannette Y. Lee

Research output: Contribution to journalLetter

8 Scopus citations

Abstract

To the Editor: In his editorial “Searching for the Yeast Connection” (Dec. 20 issue),1 Bennett noted, “The study by Dismukes et al. [Dec. 20 issue2] was carefully designed and the data thoughtfully analyzed.” Yet, Bennett also said that this study “is only a beginning” and “will not end the controversy.” As the author of the controversial and often maligned book The Yeast Connection?3 I would like to shine more light (and less heat) on the Candida-related complex. First, I would like to commend Dismukes and associates for carrying out their study. They showed, clearly, that nystatin alone “does.

Original languageEnglish (US)
Pages (from-to)1592-1594
Number of pages3
JournalNew England Journal of Medicine
Volume324
Issue number22
DOIs
StatePublished - May 30 1991

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'A controlled trial of nystatin for the candidiasis hypersensitivity syndrome'. Together they form a unique fingerprint.

  • Cite this

    Crook, W. G., Truss, C. O., Truss, C. V., Llabre, M. M., Cutler, R. B., Ledger, W. J., Witkin, S. S., Crandall, M., Dismukes, W. E., & Lee, J. Y. (1991). A controlled trial of nystatin for the candidiasis hypersensitivity syndrome. New England Journal of Medicine, 324(22), 1592-1594. https://doi.org/10.1056/NEJM199105303242210